126 related articles for article (PubMed ID: 25869319)
21. Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine.
Rudolf K; Eberlein W; Engel W; Pieper H; Entzeroth M; Hallermayer G; Doods H
J Med Chem; 2005 Sep; 48(19):5921-31. PubMed ID: 16161996
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.
Eftekhari S; Warfvinge K; Blixt FW; Edvinsson L
J Pain; 2013 Nov; 14(11):1289-303. PubMed ID: 23958278
[TBL] [Abstract][Full Text] [Related]
23. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
24. Examining the binding properties of MK-0974: a CGRP receptor antagonist for the acute treatment of migraine.
Moore EL; Burgey CS; Paone DV; Shaw AW; Tang YS; Kane SA; Salvatore CA
Eur J Pharmacol; 2009 Jan; 602(2-3):250-4. PubMed ID: 19084002
[TBL] [Abstract][Full Text] [Related]
25. Calcitonin gene-related peptide - beyond migraine prophylaxis.
Olesen J; Ashina M
Nat Rev Neurol; 2019 Oct; 15(10):562-564. PubMed ID: 31488896
[No Abstract] [Full Text] [Related]
26. Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.
Labruijere S; Ibrahimi K; Chan KY; Maassenvandenbrink A
Expert Opin Drug Discov; 2013 Nov; 8(11):1309-23. PubMed ID: 23962310
[TBL] [Abstract][Full Text] [Related]
27. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
[TBL] [Abstract][Full Text] [Related]
28. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
Rist B; Entzeroth M; Beck-Sickinger AG
J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
[TBL] [Abstract][Full Text] [Related]
29. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
Edvinsson L; Eftekhari S; Salvatore CA; Warfvinge K
Mol Cell Neurosci; 2011 Jan; 46(1):333-9. PubMed ID: 21040789
[TBL] [Abstract][Full Text] [Related]
30. Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraine.
Crowley BM; Stump CA; Nguyen DN; Potteiger CM; McWherter MA; Paone DV; Quigley AG; Bruno JG; Cui D; Culberson JC; Danziger A; Fandozzi C; Gauvreau D; Kemmerer AL; Menzel K; Moore EL; Mosser SD; Reddy V; White RB; Salvatore CA; Kane SA; Bell IM; Selnick HG; Fraley ME; Burgey CS
Bioorg Med Chem Lett; 2015 Nov; 25(21):4777-4781. PubMed ID: 26231160
[TBL] [Abstract][Full Text] [Related]
31. CGRP in Animal Models of Migraine.
Wattiez AS; Wang M; Russo AF
Handb Exp Pharmacol; 2019; 255():85-107. PubMed ID: 30689086
[TBL] [Abstract][Full Text] [Related]
32. Discovery of CGRP in relation to migraine.
Edvinsson L; Goadsby PJ
Cephalalgia; 2019 Mar; 39(3):331-332. PubMed ID: 30827155
[No Abstract] [Full Text] [Related]
33. Blocking CGRP in migraine patients - a review of pros and cons.
Deen M; Correnti E; Kamm K; Kelderman T; Papetti L; Rubio-Beltrán E; Vigneri S; Edvinsson L; Maassen Van Den Brink A;
J Headache Pain; 2017 Sep; 18(1):96. PubMed ID: 28948500
[TBL] [Abstract][Full Text] [Related]
34. Regulation of signal transduction by calcitonin gene-related peptide receptors.
Walker CS; Conner AC; Poyner DR; Hay DL
Trends Pharmacol Sci; 2010 Oct; 31(10):476-83. PubMed ID: 20633935
[TBL] [Abstract][Full Text] [Related]
35. Foreword: The CGRP Pathway and Migraine Prevention: Reducing the Burden of Disease.
Holland PR
Headache; 2018 May; 58 Suppl 1():1-3. PubMed ID: 29697155
[No Abstract] [Full Text] [Related]
36. Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment.
MaassenVanDenBrink A; Terwindt GM; van den Maagdenberg AMJM
Genome Med; 2018 Feb; 10(1):10. PubMed ID: 29471874
[TBL] [Abstract][Full Text] [Related]
37. The vasodilatory activity of CGRP: a response.
Bigal ME; Walter S; Rapoport AM
Headache; 2014 Apr; 54(4):748-9. PubMed ID: 24697226
[No Abstract] [Full Text] [Related]
38. CGRP as a neuropeptide in migraine: lessons from mice.
Russo AF
Br J Clin Pharmacol; 2015 Sep; 80(3):403-14. PubMed ID: 26032833
[TBL] [Abstract][Full Text] [Related]
39. Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs.
Lynch JJ; Shen YT; Pittman TJ; Anderson KD; Koblan KS; Gould RJ; Regan CP; Kane SA
Eur J Pharmacol; 2009 Nov; 623(1-3):96-102. PubMed ID: 19766109
[TBL] [Abstract][Full Text] [Related]
40. A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine.
von Mentzer B; Russo AF; Zhang Z; Kuburas A; Killoran PM; D'Aloisio V; Nizic L; Capel V; Kendall DA; Coxon CR; Hutcheon GA
J Pharm Pharmacol; 2020 Oct; 72(10):1352-1360. PubMed ID: 32588458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
